Treat and extend regimen for CRVO shows modest success

PHILADELPHIA — A treat-and-extend regimen of anti-VEGF therapy for macular edema from central retinal vein occlusion offered advantages but was less successful than a similar protocol for age-related macular degeneration, according to a study presented here.Advantages of a treat-and-extend regimen for CRVO included fewer office visits and injections, a lower risk of side effects and lower cost, Christopher J. Brady, MD, said at the Wills Eye Institute Annual Conference.

Full Story →